HYFT
ImmunoPrecise Antibodies Ltd.
1.50$
-3.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.4% | 19.1% | 19.1% | 18.6% | 20.8% | 45.6% | 42.2% | 89.0% | 83.3% | 81.7% | 75.9% | 70.5% | |
| 8.0% | 7.9% | 5.8% | 6.6% | 5.9% | 28.4% | 24.0% | 12.0% | 63.2% | 60.9% | 53.1% | 44.0% | |
| 8.0% | 7.9% | 5.8% | 6.6% | 5.9% | 28.4% | 24.0% | 79.6% | 63.2% | 60.9% | 53.1% | 44.0% | |
| 6.2% | 5.7% | 6.8% | 5.9% | 8.8% | 10.7% | 10.8% | 6.4% | 16.1% | 13.3% | 16.8% | 18.6% | |
| 3.2% | 3.2% | 3.6% | 3.1% | 3.3% | 4.2% | 4.7% | 1.3% | 2.0% | 2.1% | 2.3% | 3.5% | |
| 25.0% | 23.7% | 12.8% | 13.2% | 13.2% | 17.3% | 18.5% | 0.0% | 0.0% | 0.0% | 0.0% | – | |
| 38.3% | 35.4% | 39.3% | 39.5% | 38.3% | 2.5% | 2.4% | – | – | – | – | – | |
| 31.2% | 36.7% | 43.5% | 44.5% | 45.5% | 44.8% | 46.8% | 49.1% | 32.2% | 35.7% | 45.0% | 60.1% | |
| 10.0% | 11.5% | 13.5% | 18.8% | 20.7% | 19.6% | 20.3% | 41.0% | 19.9% | 22.3% | 27.1% | 38.3% | |
| 1.3% | 3.9% | 4.5% | 7.1% | 7.9% | 3.7% | 4.2% | 1.0% | 2.8% | 1.8% | 2.1% | 2.8% | |
| 3.6% | 3.8% | 5.9% | 8.1% | 9.0% | 9.6% | 11.9% | 8.0% | 13.1% | 14.4% | 19.5% | 31.4% | |
| 68.8% | 63.3% | 56.5% | 55.3% | 54.4% | 55.2% | 53.2% | 50.9% | 67.8% | 64.3% | 55.0% | 39.9% | |
| -104.8% | -104.5% | -167.1% | -172.8% | -175.1% | -278.1% | -289.8% | -323.3% | -516.9% | -601.1% | -667.8% | -859.1% | |
| 33.1% | 32.8% | 44.9% | 45.7% | 46.9% | 72.1% | 74.5% | 97.3% | 176.8% | 272.7% | 218.9% | 270.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.